Tumour driver mutations compromise between cancer growth and immune responses


Numerous theories have tried to elucidate the frequency and consistency of ‘hotspot’ mutations in lots of tumour-driving genes throughout completely different cancers. A mannequin of the health profit of those mutations reveals that basic trade-offs happen between a tumour’s development and its visibility to the immune system, with potential therapeutic implications.

Leave a Reply